FOLH1 and prostate cancer: This could allow using SRF data from a PSMA PET/CT, performed as part of initial prostate cancer staging, as baseline when investigating suspect renal impairment related to urinary obstruction, e.g. with [99mTc]Tc-MAG3 renography.